v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 312,779 $ 148,134
General and administrative 33,071 32,659
Total operating expenses 345,850 180,793
Loss from operations (345,850) (180,793)
Other income, net:    
Interest income 26,610 32,935
Other income (expense) (1,382) 7,140
Total other income, net 25,228 40,075
Net loss $ (320,622) $ (140,718)
Net loss per share, basic (in dollars per share) $ (2.30) $ (1.04)
Net loss per share, diluted (in dollars per share) $ (2.30) $ (1.04)
Weighted-average shares outstanding, basic (in shares) 139,506,680 135,690,949
Weighted-average shares outstanding, diluted (in shares) 139,506,680 135,690,949